Stock Screener App

Frei - Play StoreApp Store

Installieren Installieren

KARD

$15.568.66%1.24

Nachbörslich: 15.560.00 0.00%

Kardigan Inc (KARD)

Date: O: H: L: C: Vol:

Kardigan Inc Aktie (KARD) Neueste Nachrichten

Gyre Therapeutics, Inc. (GYRE) Stock Price & News - Syfe

RZLT Stock Price, Quote & News - Syfe

CorMedix Inc. (CRMD) Stock Price & News - Syfe

A 48,368-option grant at Kardigan (KARD) vests monthly over three years. - Stock Titan

Director Kristin Marie K. Reinke is identified in Kardigan (KARD)'s initial ownership statement. - Stock Titan

LB Pharmaceuticals Inc (LBRX) Stock Price & News - Syfe

Neurogene Inc. (NGNE) Stock Price & News - Syfe

Kardigan: Funded Precision Cardiology Offers More Than Pipeline Diversification - Seeking Alpha

Kardigan at Cantor conference: platform bet on heart drugs - Investing.com

Kardigan at Cantor conference: platform bet on heart drugs By Investing.com - Investing.com Canada

Kardigan at Cantor conference: platform bet on heart drugs By Investing.com - Investing.com UK

Nuvectis Pharma, Inc. (NVCT) Stock Price & News - Syfe

Lyell Immunopharma, Inc. (LYEL) Stock Price & News - Syfe

KARD - Kardigan Inc Short Interest - Finviz

Kardigan to Present at Two September Investor Conferences - Yahoo Finance

Kardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ Radar - TipRanks

Kardigan’s Tonlamarsen Trial Targets Severe Hypertension: What Investors Should Watch - TipRanks

KARD Should I Buy - Intellectia AI

Kardigan (NASDAQ:KARD) Price Target Cut to $46.00 by Analysts at JPMorgan Chase & Co. - marketbeat.com

Will KARD be a Portfolio Killer in August? - Zacks Investment Research

Inside cardiovascular biotech Kardigan’s June IPO - CFO Brew

Kardigan Q2 Results: EPS misses estimates by 549.3% - scanx.trade

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates - BioSpace

Kardigan Inc. Announces Q2 2026 Financial Results and Clinical Trial Updates - Kalkine Media

Kardigan Q2 Per-Share Loss Narrows - marketscreener.com

Kardigan, Inc. 2Q 2026: Net loss $116.2M, EPS $(4.61) — 10-Q Summary - TradingView

Earnings Flash (KARD) Kardigan Posts Q2 Loss $4.61 a Share - marketscreener.com

Kardigan: Q2 Earnings Snapshot - AOL.com

Kardigan: Q2 Earnings Snapshot - KTVB

Kardigan, Inc. (NASDAQ:KARD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Kardigan reports Q2 2026 net loss $116.2M, cash $660.7M after IPO - TradingView

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates - Business Wire

Kardigan Ord Shs (KARD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Kardigan (KARD) Institutional Ownership 2026 $KARD - marketbeat.com

KARD: NA - Detailed Earnings Estimates - Zacks Investment Research

Kardigan Ord Shs (KARD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Kardigan, Inc. Revenue Breakdown – NASDAQ:KARD - TradingView

Latest KARD ETF News Today | Earnings, Events & Price Alerts - Intellectia AI

KARD|Kardigan Ord Shs|Price:21.150|Chg%:+0.410 - TradingKey

Price to earnings ratio of Kardigan, Inc. – BOATS:KARD - TradingView

Kardigan, Inc. (NASDAQ:KARD) Short Interest Up ∞ in June - MarketBeat

Hrtg Pv, L.p. Net Worth (2026) - GuruFocus

Kevin Anthony Kelly Net Worth (2026) - GuruFocus

Schf Cif 2024, L.p. Net Worth (2026) - GuruFocus

Keith Bryon Johnson Net Worth (2026) - GuruFocus

Kardigan, Inc.: Target Price Consensus and Analysts Recommendations | KARD | US4859251013 - marketscreener.com

Kardigan, Inc.: Revenue and Earnings Analysts Forecasts Revisions | KARD | US4859251013 - marketscreener.com

A Quick Look at Today's Ratings for Kardigan(KARD.US), With a Forecast Between $37 to $51 - Moomoo

Kardigan (KARD) grants 20,706 RSUs tied to Perceptive-linked director pay - Stock Titan

KARD Initiated Coverage by TD Cowen -- Price Target Announced at $46 - GuruFocus

Ähnlich wie KARD

GPCR$20.360.05%

RAPP$25.931.93%

TYRA$21.530.73%

ANAB$47.510.46%

DMRA$22.943.89%